Advances in Medical and Surgical Management of Thyroid Cancer 2017

Advances in Medical and Surgical Management of Thyroid Cancer is organized by The American Association of Clinical Endocrinologists (AACE) and would be held during Jan 14 - 15, 2017 at Renaissance Tampa International Plaza Hotel, Tampa, Florida, United States of America. The target audience for this medical events is basically for endocrine surgeons, ENT and head and neck surgeons, radiologists, thyroidologists and endocrinologists, nuclear medicine physicians, nurse practitioners, physician assistants, and sonographers.

Objectives:

Upon successful completion of the activity, participants should be better able to:
• Discuss evidence-based practice and current guidelines for the management of thyroid nodules and cancer
• Evaluate recent advances in imaging and surveillance in thyroid cancer
• Discuss clinical decision-making and the latest evidence for surgical and systemic management of thyroid cancer
• Corporate support will be acknowledged both verbally and in future printed materials.
• Discuss trends in thyroid cancer diagnosis
• Review clinical behavior of thyroid microcancers
• Summarize current and future management of low risk thyroid cancer
• Review features of benign and malignant nodules
• Highlight importance of pattern recognition for risk of malignancy assessment
• Discuss current guidelines for nodule FNA
• Understand the benefits and limitations of commercially available molecular genetic test methods
• Become familiar with the evolving use of molecular genetic testing for thyroid cancer prognosis
• Describe Key morphologic features of thyroid FNA specimens in light of clinical and radiologic features
• Identify causes and features of indeterminate thyroid FNA specimens
• Measure the impact of proposed changes in “Bethesda Thyroid FNA Classification Scheme” on your practice of thyroid nodule management